These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 1858425)
21. Formation of the molten globule-like state during prolonged glycation of human serum albumin. Sattarahmady N; Moosavi-Movahedi AA; Ahmad F; Hakimelahi GH; Habibi-Rezaei M; Saboury AA; Sheibani N Biochim Biophys Acta; 2007 Jun; 1770(6):933-42. PubMed ID: 17368729 [TBL] [Abstract][Full Text] [Related]
22. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. Dyer DG; Dunn JA; Thorpe SR; Bailie KE; Lyons TJ; McCance DR; Baynes JW J Clin Invest; 1993 Jun; 91(6):2463-9. PubMed ID: 8514858 [TBL] [Abstract][Full Text] [Related]
23. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins. Nagaraj RH; Monnier VM Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603 [TBL] [Abstract][Full Text] [Related]
24. Glycoxidation: the menace of diabetes and aging. Vlassara H; Palace MR Mt Sinai J Med; 2003 Sep; 70(4):232-41. PubMed ID: 12968196 [TBL] [Abstract][Full Text] [Related]
25. Protein glycation: creation of catalytic sites for free radical generation. Yim MB; Yim HS; Lee C; Kang SO; Chock PB Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527 [TBL] [Abstract][Full Text] [Related]
26. Oxygen is not required for the browning and crosslinking of protein by pentoses: relevance to Maillard reactions in vivo. Litchfield JE; Thorpe SR; Baynes JW Int J Biochem Cell Biol; 1999 Nov; 31(11):1297-305. PubMed ID: 10605822 [TBL] [Abstract][Full Text] [Related]
27. Intervention against the Maillard reaction in vivo. Monnier VM Arch Biochem Biophys; 2003 Nov; 419(1):1-15. PubMed ID: 14568003 [TBL] [Abstract][Full Text] [Related]
33. Is glucose the sole source of tissue browning in diabetes mellitus? Hunt JV; Wolff SP FEBS Lett; 1990 Aug; 269(1):258-60. PubMed ID: 2117556 [TBL] [Abstract][Full Text] [Related]
34. Nonenzymatic glycosylation, the Maillard reaction and the aging process. Monnier VM J Gerontol; 1990 Jul; 45(4):B105-11. PubMed ID: 2195101 [No Abstract] [Full Text] [Related]
35. Maillard reaction products in tissue proteins: new products and new perspectives. Thorpe SR; Baynes JW Amino Acids; 2003 Dec; 25(3-4):275-81. PubMed ID: 14661090 [TBL] [Abstract][Full Text] [Related]
36. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies. Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253 [TBL] [Abstract][Full Text] [Related]
37. N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Reddy S; Bichler J; Wells-Knecht KJ; Thorpe SR; Baynes JW Biochemistry; 1995 Aug; 34(34):10872-8. PubMed ID: 7662668 [TBL] [Abstract][Full Text] [Related]
38. Historical perspective of the Maillard reaction in food science. Finot PA Ann N Y Acad Sci; 2005 Jun; 1043():1-8. PubMed ID: 16037216 [TBL] [Abstract][Full Text] [Related]
39. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Monnier VM; Cerami A Science; 1981 Jan; 211(4481):491-3. PubMed ID: 6779377 [TBL] [Abstract][Full Text] [Related]
40. Advanced glycation end products of the Maillard reaction and their relation to aging. Horiuchi S; Araki N Gerontology; 1994; 40 Suppl 2():10-5. PubMed ID: 7926861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]